Red, in the Cytosorbents trial I mentioned, the CEO knew of the trial irregularities and never disclosed it. I can't remember exactly what he used as the justification, something to the effect that they don't have to report on every detail in a trial, just the outcome. He said he didn't consider it material!
Market Data 
Markets 
AI
